Trial 'No Longer Warranted' After Judge's Stelara Reversal
By Bryan Koenig · January 15, 2026, 7:56 PM EST
The fate of insurer CareFirst's suit accusing Johnson & Johnson of using a merger and patent fraud to anticompetitively protect immunosuppressive drug Stelara from competition is in doubt after a Virginia...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login